It is inevitable that the value will double. I don't think it will be in 2020. At least 2026 IMO. It will depend on how quickly and how successful the various clinical trials will be and new markets. CHINA is still an untap market.
It is inevitable that the value will double. I don't think it...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.80 |
Change
2.460(0.81%) |
Mkt cap ! $148.7B | |||
| Open | High | Low | Value | Volume |
| $305.41 | $308.69 | $304.34 | $158.2M | 514.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13 | $307.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.80 | 4197 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |